Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study
INTRODUCTION: Cerebral palsy is the most common cause of physical disability in children. Spasticity is a disabling clinical symptom that is prevalent among patients suffering from cerebral palsy. The treatment of spasticity with botulinum toxin type A (BTX-A) is a well-established option in the int...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier España
2010-01-01
|
| Saila: | Clinics |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000600009 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|